CCO Independent Conference Coverage

2007 Conference on Retroviruses and Opportunistic Infections*

February 25-28, 2007 | Los Angeles, California

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

First-Line Therapy and Switch Strategies

Track 1 of 6
Capsule Summaries
Expert Analysis

Faculty:

David A. Cooper, MD, DScJoel E. Gallant, MD, MPHKimberly Y. Smith, MD, MPH
  • David A. Cooper, MD, DSc
  • Joel E. Gallant, MD, MPH
  • Kimberly Y. Smith, MD, MPH

Resistance and Management of Treatment-Experienced Patients

Track 2 of 6
Capsule Summaries
Expert Analysis

Faculty:

W. David Hardy, MDKathleen E. Squires, MDAndrew R. Zolopa, MD
  • W. David Hardy, MD
  • Kathleen E. Squires, MD
  • Andrew R. Zolopa, MD

Investigational Antiretrovirals

Track 3 of 6
Capsule Summaries
Expert Analysis
CCO Expert Recap
CCO Slideset

Faculty:

Joseph J. Eron, Jr., MDDaniel R. Kuritzkes, MDWilliam G. Powderly, MD
  • Joseph J. Eron, Jr., MD
  • Daniel R. Kuritzkes, MD
  • William G. Powderly, MD

Current Issues in Antiretroviral Therapy

Track 4 of 6
Expert Analysis

Faculty:

Pedro Cahn, MD, PhDRoy M. Gulick, MD, MPHJoep MA Lange, MD, PhD
  • Pedro Cahn, MD, PhD
  • Roy M. Gulick, MD, MPH
  • Joep MA Lange, MD, PhD

Metabolic Complications and Adverse Events

Track 5 of 6
Capsule Summaries
Expert Analysis

Faculty:

Judith S. Currier, MD, MScSally Hodder, MDDonald P. Kotler, MD
  • Judith S. Currier, MD, MSc
  • Sally Hodder, MD
  • Donald P. Kotler, MD

Hepatitis and Opportunistic Diseases

Track 6 of 6
Capsule Summaries
Expert Analysis

Faculty:

Richard E. Chaisson, MDBruce Polsky, MDJürgen K. Rockstroh, MD
  • Richard E. Chaisson, MD
  • Bruce Polsky, MD
  • Jürgen K. Rockstroh, MD

CME-Certified Slideset

Review and download slides summarizing the most clinically relevant data on antiretroviral therapy and complications of HIV disease at the recent Retrovirus meeting Los Angeles.

This slide presentation is in Microsoft PowerPoint format and is available for download within the CME module.

Metabolic Complications: Update From Los Angeles

Faculty:

Judith S. Currier, MD, MScJoseph J. Eron, Jr., MDJoel E. Gallant, MD, MPH
  • Judith S. Currier, MD, MSc
  • Joseph J. Eron, Jr., MD
  • Joel E. Gallant, MD, MPH
Sally Hodder, MDDonald P. Kotler, MDWilliam G. Powderly, MD
  • Sally Hodder, MD
  • Donald P. Kotler, MD
  • William G. Powderly, MD
Kimberly Y. Smith, MD, MPHAndrew R. Zolopa, MD
  • Kimberly Y. Smith, MD, MPH
  • Andrew R. Zolopa, MD

CME CREDIT INFORMATION

Release Date: 04/05/07

Expiration Date: 04/04/08


Physicians: maximum of 0.5 AMA PRA Category 1 Credits™

Status: Please log in to view status
Begin the CCO Slideset

Distinguished faculty review the most clinically relevant new data from the Retrovirus meetings in Los Angeles, February 2007.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe observations about the natural history of HIV infection and the development of metabolic complications
  • Specify data on metabolic complications observed in recent studies of approved and investigational antiretroviral agents
  • Discuss recent insights into the management and prevention of metabolic complications in HIV-infected patients

CCO Slideset – Metabolic Complications: Update From Los Angeles


Format: Microsoft PowerPoint (.ppt) | File size: 513 KB


Expert Highlights (mp3)

Listen to the experts summarize the most important data from the Los Angeles meeting with our exclusive CCO Podcasts!

These audio files are in mp3 format. To listen to the audio, simply click "Download Audio." You must be logged onto the clinicaloptions.com site to listen to or download the mp3 files.

Joseph J. Eron, Jr., MD headshot

Joseph J. Eron, Jr, MD, notes that there were very few reports on drugs in early clinical development at this meeting and discusses the implications of that for treatment of highly experienced patients.
(3 minutes)

 Download Audio
Judith S. Currier, MD, MSc headshot

Judith S. Currier, MD, MSc, reviews data from 2 antiretroviral clinical studies that provide information on strategies to decrease treatment-related lipoatrophy in HIV-infected patients. (4 minutes)

 Download Audio
Bruce Polsky, MD headshot

Bruce Polsky, MD, reviews key presentations on the management of coinfections in HIV-infected patients including TB-related testing, morbidity and mortality, impact of unsafe sexual practices on acute HCV infection in men who have sex with men, and surprising results that may impact the use of entecavir for the treatment of HBV/HIV-coinfected patients. (10 minutes)

 Download Audio
W. David Hardy, MD headshot

W. David Hardy, MD, discusses the results of phase 3 studies of raltegravir (MK-0518) and maraviroc in triple-class-experienced patients, and highlights the availability of these agents, as well as etravirine, through expanded access programs. (3 minutes)

 Download Audio
Joel E. Gallant, MD, MPH headshot

Joel Gallant, MD, MPH, discusses the phase IIb comparison of TMC278, a second generation NNRTI, with efavirenz in antiretroviral-naive patients and notes that this agent may challenge efavirenz in this arena. (3 minutes)

 Download Audio

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grants provided by:

Educational grants support only the CME-certified components of this program.